Delivery Order SPE2DR25D1202-SPE2DR26F72GF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units) with a contract ceiling value of $1,824.59. This is a firm fixed-price delivery order with an ultimate completion date of May 6, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 15 mg tablets (100 count) on October 22, 2025, with a ceiling value of $21,481.96. This firm fixed-price delivery order is non-set-aside and represents a competitive award to fulfill federal pharmaceutical supply requirements. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of OxyContin ER 10 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $1,955.66, is set to be completed by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis, indicating open competitive procurement. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of OxyContin ER 15 mg tablets (100-count units) with a ceiling value of $1,099.09. This competitively awarded, non-set-aside delivery order is priced on a firm fixed-price basis and is scheduled for completion by September 10, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete delivery order fulfilling...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of OxyContin ER 30 mg tablets (100 count) with a contract value of $7,759.02. This is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and represents a non-set-aside competitive award. The pharmaceutical supply will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,437.52 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units). The contract is classified as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) with a contract ceiling value of $1,490.43. This competitively awarded delivery order employs firm fixed pricing with an ultimate completion date of November 10, 2025. The contract is issued without a set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,235.90 to AmerisourceBergen Drug Corp for OxyContin ER 15 mg tablets (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,842.35. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 13, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a continuation of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,946.92, with an ultimate completion date of November 17, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on November 14, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader federal...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72GFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of OxyContin ER 15 mg tablets (100-count units) with a ceiling value of $1,447.96. This is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, consistently demonstrating the capability to meet federal requirements through open competition across diverse therapeutic domains and order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/17/25 |